123 related articles for article (PubMed ID: 34923245)
1. Evaluation of IFN-γ secretion after stimulation with C. neoformans and C. gattii antigens in individuals with frequent exposure to the fungus.
Maciel IF; de Freitas-Xavier RS; Vicentini AP; Apoliano CF; Ruiz Fernandes J; Dias ADS; Gimenes VFM; Benard G; Vasconcelos DM
J Mycol Med; 2022 May; 32(2):101230. PubMed ID: 34923245
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
4. Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area.
Cogliati M; Desnos-Ollivier M; McCormick-Smith I; Rickerts V; Ferreira-Paim K; Meyer W; Boekhout T; Hagen F; Theelen B; Inácio J; Alonso B; Colom MF; Trilles L; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencá ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Pasquale V; Polacheck I; Lockhart SR
Fungal Genet Biol; 2019 Aug; 129():16-29. PubMed ID: 30953839
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Vitek MS for Differentiation of
Siqueira LPM; Gimenes VMF; de Freitas RS; Melhem MSC; Bonfietti LX; da Silva AR; Souza Santos LB; Motta AL; Rossi F; Benard G; de Almeida JN
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30429250
[No Abstract] [Full Text] [Related]
6. Molecular characterization of Cryptococcus neoformans and Cryptococcus gattii from environmental sources and genetic comparison with clinical isolates in Apulia, Italy.
Montagna MT; De Donno A; Caggiano G; Serio F; De Giglio O; Bagordo F; D'Amicis R; Lockhart SR; Cogliati M
Environ Res; 2018 Jan; 160():347-352. PubMed ID: 29054089
[TBL] [Abstract][Full Text] [Related]
7. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
8. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Espinel-Ingroff A; Chowdhary A; Cuenca-Estrella M; Fothergill A; Fuller J; Hagen F; Govender N; Guarro J; Johnson E; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; Trilles L; Kidd S; Turnidge J
Antimicrob Agents Chemother; 2012 Jun; 56(6):3107-13. PubMed ID: 22391546
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
11. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.
Cogliati M; D'Amicis R; Zani A; Montagna MT; Caggiano G; De Giglio O; Balbino S; De Donno A; Serio F; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Oliveri S; Trovato L; Dipineto L; Rickerts V; McCormick-Smith I; Akcaglar S; Tore O; Mlinaric-Missoni E; Bertout S; Mallié M; Martins Mda L; Vencà AC; Vieira ML; Sampaio AC; Pereira C; Criseo G; Romeo O; Ranque S; Al-Yasiri MH; Kaya M; Cerikcioglu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Korem M; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Theelen B; Boekhout T; Lockhart SR; Tintelnot K; Tortorano AM; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Alonso B; Colom MF
FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27188887
[TBL] [Abstract][Full Text] [Related]
12. MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.
Firacative C; Trilles L; Meyer W
PLoS One; 2012; 7(5):e37566. PubMed ID: 22666368
[TBL] [Abstract][Full Text] [Related]
13. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties.
Ngamskulrungroj P; Gilgado F; Faganello J; Litvintseva AP; Leal AL; Tsui KM; Mitchell TG; Vainstein MH; Meyer W
PLoS One; 2009 Jun; 4(6):e5862. PubMed ID: 19517012
[TBL] [Abstract][Full Text] [Related]
16. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
[TBL] [Abstract][Full Text] [Related]
17. Determination of molecular types and genetic heterogeneity of Cryptococcus neoformans and C. gattii in Malaysia.
Tay ST; Lim HC; Tajuddin TH; Rohani MY; Hamimah H; Thong KL
Med Mycol; 2006 Nov; 44(7):617-22. PubMed ID: 17071555
[TBL] [Abstract][Full Text] [Related]
18. Frequency and geographical distribution of genotypes and mating types of Cryptococcus neoformans and Cryptococcus gattii species complexes in Argentina.
Taverna CG; Bosco-Borgeat ME; Mazza M; Vivot ME; Davel G; Canteros CE;
Rev Argent Microbiol; 2020; 52(3):183-188. PubMed ID: 31948732
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
20. Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015.
Vélez N; Escandón P
Mem Inst Oswaldo Cruz; 2016 Oct; 111(10):642-648. PubMed ID: 27706379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
